Home/BioSyn/Dr. S.N. Muddukrishna
DS

Dr. S.N. Muddukrishna

President and CEO

BioSyn

BioSyn Pipeline

DrugIndicationPhase
IMMUCOTHEL® / VACMUNE® (KLH)Carrier protein/adjuvant for investigational vaccines (Cancer, Infectious Disease)Phase 1-4 (as component)
REASSOCIATED NATIVE KLH (RANKLH)Advanced carrier protein/adjuvant for research and clinical useResearch / Pre-clinical
Selenase® (Sodium Selenite)Selenium deficiency in Sepsis, Critical Care, SurgeryApproved (ex-US) / Investigational (US)